FFA
HAE icon

Farther Finance Advisors’s Haemonetics HAE Stock Holding History

Farther Finance Advisors’s Portfolio HAE Stock Details HAE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$45.5K Sell
607
-25
-4% -$1.61K ﹤0.01% 3310
2026
Q1 		$35.5K Sell
632
-155
-20% -$10.1K ﹤0.01% 3234
2025
Q4 		$63.1K Buy
787
+677
+615% +$45.5K ﹤0.01% 2660
2025
Q3 		$5.36K Hold
110
– – ﹤0.01% 3730
2025
Q2 		$8.21K Buy
110
+43
+64% +$2.85K ﹤0.01% 3174
2025
Q1 		$4.22K Buy
67
+31
+86% +$2.11K ﹤0.01% 3134
2024
Q4 		$2.81K Hold
36
– – ﹤0.01% 2879
2024
Q3 		$2.89K Buy
36
+1
+3% +$81 ﹤0.01% 2859
2024
Q2 		$2.9K Hold
35
– – ﹤0.01% 2638
2024
Q1 		$2.97K Sell
35
-5
-13% -$392 ﹤0.01% 2323
2023
Q4 		$3.42K Buy
40
+28
+233% +$2.42K ﹤0.01% 2167
2023
Q3 		$1.07K Buy
+12
New +$1.07K ﹤0.01% 2064

Other funds holding HAE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Farther Finance Advisors's HAE Position: Q2 2026 in Review

Farther Finance Advisors reduced its Haemonetics (HAE) stake by 4% in Q2 2026, selling an estimated $1.61K and leaving 607 shares worth $45.5K. The position accounts for ﹤0.01% of the portfolio, ranked #3310.

Farther Finance Advisors first reported a position in HAE in Q3 2023 and has held it in 12 quarters since. The position peaked at $63.1K in Q4 2025. 329 funds tracked by Wall St. Rank hold HAE as of Q2 2026.

  • Farther Finance Advisors held 607 shares of Haemonetics worth $45.5K as of Q2 2026.
  • Farther Finance Advisors sold 25 Haemonetics shares in Q2 2026, an estimated $1.61K.
  • Haemonetics made up ﹤0.01% of Farther Finance Advisors's portfolio in Q2 2026, its #3310 holding.
  • Farther Finance Advisors first reported a position in Haemonetics in Q3 2023 and has held it in 12 quarters since.
  • Farther Finance Advisors's Haemonetics position peaked at $63.1K in Q4 2025.
  • 329 funds tracked by Wall St. Rank held Haemonetics as of Q2 2026.

Based on Farther Finance Advisors's 13F filing for Q2 2026, filed 17 Jul 2026.